Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
about
Towards Stratified Medicine in Plasma Cell MyelomaDifferentiation stage of myeloma plasma cells: biological and clinical significance.Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming.Microenvironment drug resistance in multiple myeloma: emerging new players.VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma.Standardisation of minimal residual disease in multiple myeloma.Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow.Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era.JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma.Minimal residual disease analysis in myeloma - when, why and where.Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials.
P2860
Q28074994-29A71BF0-8949-40E1-B03A-C380FE11D1ADQ33712516-63BDB482-9CD9-4568-B0B0-2E60D84E0973Q37684348-08A9B297-FAE8-451C-9F49-E18092AAEBDAQ38913083-019FA029-67D2-4939-A06F-67E8A5F099D9Q39103567-A39A99DB-AC6C-466C-9084-9502E0801F03Q39410899-30CC0171-64DA-4176-A564-030DE7CA6256Q40109575-4F6055E2-1325-461E-957C-D023DA82EC44Q41091821-0D0D475A-647B-4CA0-8B7B-609934B53CC9Q47610951-C423D9E9-A0EE-44EC-B214-3285FC233C0DQ48041020-AE07EC96-1DB0-466D-86D7-5E685C3B7C04Q50092746-CD32EE68-5E85-4E39-B7D7-DC58FBCD065CQ53831599-A48CF617-3CDB-4D5C-95C1-0D306033EED9
P2860
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Phenotypic and genomic analysi ...... to understand chemoresistance.
@en
Phenotypic and genomic analysi ...... to understand chemoresistance.
@nl
type
label
Phenotypic and genomic analysi ...... to understand chemoresistance.
@en
Phenotypic and genomic analysi ...... to understand chemoresistance.
@nl
prefLabel
Phenotypic and genomic analysi ...... to understand chemoresistance.
@en
Phenotypic and genomic analysi ...... to understand chemoresistance.
@nl
P2093
P50
P1433
P1476
Phenotypic and genomic analysi ...... to understand chemoresistance.
@en
P2093
Alberto Orfao
Bart Barlogie
Bruno Paiva
Diego Alignani
Felipe De Arriba
Idoia Rodriguez
Joan Blade
Joshua Epstein
Juan José Lahuerta
Leire Burgos
P304
P356
10.1182/BLOOD-2015-08-665679
P407
P577
2016-01-11T00:00:00Z